Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). „Lancet”. 344 (8934), s. 1383–1389, 1994. DOI: 10.1016/S0140-6736(94)90566-5. PMID: 7968073.
T.J. Smilde, S. van Wissen, H. Wollersheim, M.D. Trip i inni. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. „Lancet”. 357 (9256), s. 577–581, 2001. DOI: 10.1016/S0140-6736(00)04053-8. PMID: 11558482.
R. Collins, J. Armitage, S. Parish, P. Sleight i inni. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. „Lancet”. 363 (9411), s. 757–767, 2004. DOI: 10.1016/S0140-6736(04)15690-0. PMID: 15016485.
Piecha, Małgorzata, Sarakha, Mohamed, Trebse, Polonca, Kocar, Drago. Stability studies of cholesterol lowering statin drugs in aqueous samples using HPLC and LC-MS. „Environ Chem Lett”. 8 (2), s. 185–191, 2010. DOI: 10.1007/s10311-009-0207-0.
Jadwiga Mielcarek, M. Naskrent, P. Grobelny. Photochemical properties of simvastatin and lovastatin induced by radiation. „Journal of Thermal Analysis and Calorimetry”. 96 (1), s. 301–305, 2009. DOI: 10.1007/s10973-008-9322-6. ISSN1388-6150. (ang.).
Piecha, Małgorzata, Sarakha, Mohamed, Trebse, Polonca. Photocatalytic degradation of cholesterol-lowering statin drugs by TiO2-based catalyst. Kinetics, analytical studies and toxicity evaluation. „Journal of Photochemistry and Photobiology A: Chemistry”. 213 (1), s. 61–69, 2010. DOI: 10.1016/j.jphotochem.2010.04.020.
D.M. Feidt, K. Klein, U. Hofmann, S. Riedmaier i inni. Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes. „Drug Metab Dispos”. 38 (9), s. 1589–1597, 2010. DOI: 10.1124/dmd.110.033886. PMID: 20551241.
M. Hu, V.W.L. Mak, T.T.W. Chu, M.M.Y. Waye, B. Tomlinson. Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease Current Pharmacogenomics and Personalized Medicine. „Current Pharmacogenomics and Personalized Medicine”. 7 (1), s. 1–26, 2009. DOI: 10.2174/187569209787582349. (ang.).
E. Link, S. Parish, J. Armitage, L. Bowman i inni. SLCO1B1 variants and statin-induced myopathy – a genomewide study. „N Engl J Med”. 359 (8), s. 789–799, 2008. DOI: 10.1056/NEJMoa0801936. PMID: 18650507.
K. S. Keshava Murthy, Stephen E. Horne, Gamini Weeratunga, Shawn Young: Patent US6307066. Process for producing simvastatin. Brantford Chemicals Inc., 1996 (data zgłoszenia); 2001 (data publikacji). [dostęp 2014-07-11]. (ang.).
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). „Lancet”. 344 (8934), s. 1383–1389, 1994. DOI: 10.1016/S0140-6736(94)90566-5. PMID: 7968073.
T.J. Smilde, S. van Wissen, H. Wollersheim, M.D. Trip i inni. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. „Lancet”. 357 (9256), s. 577–581, 2001. DOI: 10.1016/S0140-6736(00)04053-8. PMID: 11558482.
R. Collins, J. Armitage, S. Parish, P. Sleight i inni. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. „Lancet”. 363 (9411), s. 757–767, 2004. DOI: 10.1016/S0140-6736(04)15690-0. PMID: 15016485.
A. Endo. A historical perspective on the discovery of statins. „Proc Jpn Acad Ser B Phys Biol Sci”. 86 (5), s. 484–493, 2010. PMID: 20467214. (ang.).
D.M. Feidt, K. Klein, U. Hofmann, S. Riedmaier i inni. Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes. „Drug Metab Dispos”. 38 (9), s. 1589–1597, 2010. DOI: 10.1124/dmd.110.033886. PMID: 20551241.
S. Vickers, C.A. Duncan, K.P. Vyas, P.H. Kari i inni. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. „Drug Metab Dispos”. 18 (4), s. 476–483, 1990. PMID: 1976071.
E. Link, S. Parish, J. Armitage, L. Bowman i inni. SLCO1B1 variants and statin-induced myopathy – a genomewide study. „N Engl J Med”. 359 (8), s. 789–799, 2008. DOI: 10.1056/NEJMoa0801936. PMID: 18650507.
Jadwiga Mielcarek, M. Naskrent, P. Grobelny. Photochemical properties of simvastatin and lovastatin induced by radiation. „Journal of Thermal Analysis and Calorimetry”. 96 (1), s. 301–305, 2009. DOI: 10.1007/s10973-008-9322-6. ISSN1388-6150. (ang.).